Drug Trial Radar · NCT07161544
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
Last checked: Nov 19, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
75
Planned (sponsor's estimate)
Start
Sep 29, 2025
Primary completion
Jul 2032
Study completion Jul 2032
Sponsor
- Lead sponsor
- AAVantgarde Bio SrlIndustry
- Sponsor type
- Industry
- Collaborators
- AAVantgarde Bio UK Ltd
- First posted
- Sep 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 8 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the 039-101 study is to evaluate the safety and tolerability of a single subretinal injection of AAVB-039 in participants with Stargardt disease secondary to a biallelic mutation of the ABCA4 gene. The study will also assess initial efficacy following AAVB-039 administration.
Conditions
- Stargardt Disease
Interventions
AAVB-039Biological
Single subretinal administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- To measure the number and severity of treatment related adverse events following treatment with AAVB-039Time frame: 0-60 months
Locations
11 sites in 3 countries. Site status is shown where the registry gives one.
Associated Retina Consultants
Phoenix, Arizona · Recruiting
Children's Hospital Los Angeles
Los Angeles, California · Recruiting
Retina Vitreous Associates Medical Group
Los Angeles, California · Recruiting
University of Florida Health Science Center
Jacksonville, Florida · Recruiting
Mayo Clinic
Rochester, Minnesota · Recruiting
Retina Consultants of Texas
Bellaire, Texas · Recruiting
Retina Foundation of the Southwest
Dallas, Texas · Recruiting
University of Utah
Salt Lake City, Utah · Recruiting
Oslo University Hospital
Oslo, Kirkeveien 166, Norway · Recruiting
Moorfields Eye Hospital NHS Foundation Trust
London, England, United Kingdom · Recruiting
The Retina Clinic
London, England, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.